95 related articles for article (PubMed ID: 16441769)
41. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection.
Scheepstra C; Bemelman FJ; van der Loos C; Rowshani AT; van Donselaar-Van der Pant KA; Idu MM; ten Berge IJ; Florquin S
Transplantation; 2008 Sep; 86(6):772-8. PubMed ID: 18813100
[TBL] [Abstract][Full Text] [Related]
42. Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies.
Quiroga I; Salio M; Koo DD; Cerundolo L; Shepherd D; Cerundolo V; Fuggle SV
Transplantation; 2006 Apr; 81(8):1196-203. PubMed ID: 16641608
[TBL] [Abstract][Full Text] [Related]
43. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
[TBL] [Abstract][Full Text] [Related]
44. Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens.
Martins HL; Silva C; Martini D; Noronha IL
Transplant Proc; 2007 Mar; 39(2):432-4. PubMed ID: 17362749
[TBL] [Abstract][Full Text] [Related]
45. Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients.
Dijke IE; Velthuis JH; Caliskan K; Korevaar SS; Maat AP; Zondervan PE; Balk AH; Weimar W; Baan CC
Transplantation; 2007 Jun; 83(11):1477-84. PubMed ID: 17565321
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic efficacy of C4d immunostaining in the detection of the humoral component of renal allograft rejection and therapeutic implications.
Guduru SL; Kuruvilla S; Abraham G; Mathew M; Saravanan S
Indian J Pathol Microbiol; 2009; 52(3):345-8. PubMed ID: 19679957
[TBL] [Abstract][Full Text] [Related]
47. A quantitative study of the renal corpuscles in acute renal allograft rejection.
Sorensen FH
Acta Pathol Microbiol Scand A; 1977 May; 85(3):367-72. PubMed ID: 327751
[TBL] [Abstract][Full Text] [Related]
48. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database.
Simpson N; Cho YW; Cicciarelli JC; Selby RR; Fong TL
Transplantation; 2006 Nov; 82(10):1298-303. PubMed ID: 17130778
[TBL] [Abstract][Full Text] [Related]
49. Analysis of different staining techniques for c4d detection in renal allograft biopsies.
Ludovico-Martins H; Silva C; Teodoro WR; Martini Filho D; Noronha IL
Transplant Proc; 2009 Apr; 41(3):862-5. PubMed ID: 19376373
[TBL] [Abstract][Full Text] [Related]
50. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
51. TGF-beta1 in chronic allograft nephropathy following renal transplantation.
Harris S; Coupes BM; Roberts SA; Roberts IS; Short CD; Brenchley PE
J Nephrol; 2007; 20(2):177-85. PubMed ID: 17514622
[TBL] [Abstract][Full Text] [Related]
52. Induction of cyclo-oxygenase-2 by acute liver allograft rejection and cytomegalovirus infection in the rat.
Martelius TJ; Wolff H; Bruggeman CA; Höckerstedt KA; Lautenschlager IT
Transpl Int; 2002 Dec; 15(12):610-4. PubMed ID: 12478407
[TBL] [Abstract][Full Text] [Related]
53. [Expression of peroxisome proliferators-activated receptor-gamma and cyclooxygenase-2 in Helicobacter pylori infection-associated diseases and significance thereof].
Xie Y; Zhu J; Zhou XJ; Chen J; Lu NH; Wang CW
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2683-9. PubMed ID: 17199977
[TBL] [Abstract][Full Text] [Related]
54. Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques.
Yehia M; Matheson PJ; Merrilees MJ; Beaumont BW; Pilmore HL
Nephrology (Carlton); 2006 Jun; 11(3):261-6. PubMed ID: 16756643
[TBL] [Abstract][Full Text] [Related]
55. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2008; 59(4):189-94. PubMed ID: 19391484
[TBL] [Abstract][Full Text] [Related]
56. Expression of cyclooxygenase-1 and cyclooxygenase-2 in the normal human heart and in myocardial infarction.
Zidar N; Dolenc-Strazar Z; Jeruc J; Jerse M; Balazic J; Gartner U; Jermol U; Zupanc T; Stajer D
Cardiovasc Pathol; 2007; 16(5):300-4. PubMed ID: 17868881
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues.
Rossiello L; D'Andrea F; Grella R; Signoriello G; Abbondanza C; De Rosa C; Prudente M; Morlando M; Rossiello R
Wound Repair Regen; 2009; 17(5):750-7. PubMed ID: 19769727
[TBL] [Abstract][Full Text] [Related]
58. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
[TBL] [Abstract][Full Text] [Related]
59. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function.
Scholten EM; Rowshani AT; Cremers S; Bemelman FJ; Eikmans M; van Kan E; Mallat MJ; Florquin S; Surachno J; ten Berge IJ; Bajema IM; de Fijter JW
J Am Soc Nephrol; 2006 Sep; 17(9):2622-32. PubMed ID: 16899517
[TBL] [Abstract][Full Text] [Related]
60. Adverse impact of pretransplant polyoma virus infection on renal allograft function.
Hayat A; Mukhopadhyay R; Radhika S; Sachdeva MS; Nada R; Joshi K; Sakhuja V; Jha V
Nephrology (Carlton); 2008 Apr; 13(2):157-63. PubMed ID: 18275505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
